Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

2,3-O-Isopropylidene-L-lyxono-1,4-lactone (CAS 152006-17-2)

0.0(0)
Write a reviewAsk a question

CAS Number:
152006-17-2
Molecular Weight:
188.18
Molecular Formula:
C8H12O5
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

2,3-O-Isopropylidene-L-lyxono-1,4-lactone, a compound with a cyclic structure derived from L-lyxonic acid, has garnered interest in scientific research for its versatile applications. One of its notable mechanisms of action is its ability to serve as a precursor or building block in organic synthesis, particularly in the preparation of carbohydrate derivatives and natural product analogs. Researchers have utilized this compound as a key starting material in the synthesis of various bioactive molecules, including carbohydrates, glycosides, and lactones. Its unique chemical structure and reactivity make it valuable in the development of novel synthetic methodologies and strategies for the construction of complex organic molecules. Moreover, 2,3-O-Isopropylidene-L-lyxono-1,4-lactone has been investigated for its potential applications in the synthesis of biologically active compounds with pharmaceutical relevance, although it′s essential to note that this discussion remains within the realm of basic research rather than development. Additionally, this compound has been employed as a model system in organic chemistry studies to explore reaction mechanisms, stereochemistry, and reactivity patterns, contributing to a deeper understanding of chemical processes. Its role as a versatile synthetic intermediate underscores its importance in the field of organic chemistry and highlights its potential for further exploration in the synthesis of diverse molecular scaffolds and bioactive compounds.


2,3-O-Isopropylidene-L-lyxono-1,4-lactone (CAS 152006-17-2) References

  1. Looking glass inhibitors: efficient synthesis and biological evaluation of D-deoxyfuconojirimycin.  |  Blériot, Y., et al. 2005. Carbohydr Res. 340: 2713-8. PMID: 16274755
  2. Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.  |  Rountree, JS., et al. 2009. ChemMedChem. 4: 378-92. PMID: 19145603
  3. C-3 branched δ-3,5-cis- and trans-THF sugar amino acids: synthesis of the first generation of branched homooligomers.  |  Simone, MI., et al. 2011. Amino Acids. 41: 643-61. PMID: 21350854
  4. Carbohydrate-based lactones: synthesis and applications.  |  Xavier, NM., et al. 2010. Top Curr Chem. 295: 19-62. PMID: 21626739
  5. Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds.  |  Luxenburger, A., et al. 2019. Molecules. 24: PMID: 30832206

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

2,3-O-Isopropylidene-L-lyxono-1,4-lactone, 500 mg

sc-220779
500 mg
$260.00